Use of FDG-PET imaging for patients with disseminated cancer of the appendix

American Surgeon

Volumn 76, Issue 12, 2010, Pages 1338-1344

  Rohani, Payam ^a   Scotti, Stephen D ^a   Shen, Perry ^a   Stewart, John H ^a   Russell, Gregory B ^a   Cromer, Mary ^a   Levine, Edward A ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; APPENDIX CARCINOMA; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISSEMINATED CANCER; FEMALE; HUMAN; MALE; PERITONEAL DISSEMINATION OF CARCINOMA OF APPENDICEAL ORIGIN; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SENSITIVITY ANALYSIS;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; APPENDICEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PSEUDOMYXOMA PERITONEI; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 78651367725     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Clark PB, Soo V, Kraas J, et al. Futility of fluorodeoxyglucose F 18 PET in initial evaluation of patients with T2 to T4 melanoma. Arch Surg 2006;141:284-8.
2. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006;238:405-22.
3. Ell PJ. The contribution of PET/CT to improved patient management. Br J Radiol 2006;79:32-6.
4. Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDGPET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000;174:1005-8.
5. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007;245:104-9.
6. Hasenburg A, Watermann D, Orlowska-Volk M, Gitsch G. Pseudomyxoma peritonei. Eur Clin Obstet Gynaecol 2005;1:19-23.
7. Galani E, Marx GM, Steer CB, et al. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer 2003;13:413-8.
8. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinico-pathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to pseudomyxoma peritonei. Am J Surg Pathol 1995;19:1390-408.
9. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:85-91.
10. Bradley RF, Stewart JH IV, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:551-9.
11. Low RN, Barone RM, Gurney JM, et al. Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. AJR Am J Roentgenol 2008;190:656-65.
12. Katz MH, Barone RM. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 2003;12:673-88.
13. Stewart JH IV, Shen P, Russell GB, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 2006;13:624-34.
14. Walensky RP, Venbrux AC, Prescott CA, Osterman FA Jr. Pseudomyxoma peritonei. AJR Am J Roentgenol 1996;167:471-4.
15. Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ. Pseudomyxoma peritonei. Curr Probl Surg 2008;45:527-75.
16. Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002;223:495-9.
17. Bechtold RE, Chen MY, LoggieBW, et al. CTappearance of disseminated peritoneal adenomucinosis. Abdom Imaging 2001;26:406-10.
18. Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 2008;33:87-93.
19. Pfannenberg C, Königsrainer I, Aschoff P, et al. (18) FFDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2009;16:1295-303.
20. Dirisamer A, Schima W, Heinisch M, et al. Detection of histologically proven peritoneal carcinomatosis with fused 18FFDG-PET/MDCT. Eur J Radiol 2009;69:536-41.